Reduction of aluminum ion neurotoxicity through a small peptide application – NAP treatment of Alzheimer’s disease

Alzheimer’s disease (AD) is the most common cause of dementia in late life. It is difficult to precisely diagnose AD at early stages, making biomarker search essential for further developments. The objective of this study was to identify protein biomarkers associated with aluminum ions toxicity (AD-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ming-Hui, Chen, Shih-Cheng, Lin, Yu-Fen, Lee, Yi-Chia, Huang, Ming-Yii, Chen, Ko-Chin, Wu, Hsin-Yi, Lin, Po-Chiao, Gozes, Illana, Tyan, Yu-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296191/
https://www.ncbi.nlm.nih.gov/pubmed/30987727
http://dx.doi.org/10.1016/j.jfda.2018.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296191/
https://www.ncbi.nlm.nih.gov/pubmed/30987727
http://dx.doi.org/10.1016/j.jfda.2018.11.009

Ejemplares similares